P

Inventor

METZGER AXEL

US11 patents
⚠️ This page may combine multiple inventors who share the name “METZGER AXEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VENENUM BIODESIGN LLC

3 patents
US11883420B2Jan 30, 2024

Sting agonists for treating bladder cancer and solid tumors

VENENUM BIODESIGN LLC0 citations55
US11110106B2Sep 7, 2021

Sting agonists for treating bladder cancer and solid tumors

VENENUM BIODESIGN LLC0 citations54
US11161864B2Nov 2, 2021

Sting agonists

VENENUM BIODESIGN LLC0 citations44

PHARMACOPEIA INC

2 patents
US7479495B2Jan 20, 2009

N-heterocyclic inhibitors of TNF-α expression

PHARMACOPEIA INC11 citations83
US7253174B2Aug 7, 2007

N-heterocyclic inhibitors of TNF-α expression

PHARMACOPEIA INC15 citations83

UNIV TEXAS

1 patent
US6048732AApr 11, 2000

Receptor and method for citrate determination

UNIV TEXAS118 citations97

PHARMACEOPEIA INC

1 patent
US6906067B2Jun 14, 2005

N-heterocyclic inhibitors of TNF-α expression

PHARMACEOPEIA INC35 citations89

SHI YI-QUN

1 patent
US8263608B2Sep 11, 2012

Melanocortin receptor-specific spiro-piperidine compounds

SHI YI-QUN15 citations80

PHARMACOPEIA LLC

1 patent
US7951803B2May 31, 2011

8-heteroarylpurine MNK2 inhibitors for treating metabolic disorders

PHARMACOPEIA LLC10 citations78

BRISTOL MYERS SQUIBB CO

1 patent
US8044040B2Oct 25, 2011

N-heterocyclic inhibitors of TNF-alpha expression

BRISTOL MYERS SQUIBB CO6 citations73

PALATIN TECHNOLOGIES INC

1 patent
US12459894B2Nov 4, 2025

Orally active melanocortin receptor-4 compounds

PALATIN TECHNOLOGIES INC0 citations61